Cytotoxic Activity of Unique Synthesized Five-membered Heterocyclic Compounds Coordinated with Tiopronin Monovalent
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: We recently synthesized a compound in which 5-mercapto-1-methyltetrazole (MM4) was coordinated to tiopronin monovalent (TPN-Au(I)) and reported its cytotoxic activity against human leukemia cells in vitro</i>.
OBJECTIVE: We further synthesized other heterocyclic compounds coordinated with TPN-Au(I) and assessed their cytotoxic activity against hepatocellular carcinoma HepG2 and lung cancer cell line H1299 in vitro</i>.
METHODS: Seven kinds of compounds were synthesized by introducing a five-membered heterocyclic compound into TPN-Au(I). The number of viable cells was counted by a trypan blue dye exclusion assay. Fluorescence conjugated-Annexin V and propidium iodide were used for the apoptosis analysis.
RESULTS: Seven compounds were successfully synthesized. Among these compounds, TPN-Au(I)-MTZ (3- mercapto-1,2,4-triazole), TPN-Au(I)-MMT (2-mercapto-5-methyl-1,3,4-thiadiazole), and TPN-Au(I)-MMTT (2-mercapto-5-methylthio-1,3,4-thiadiazole) effectively suppressed the proliferation and induced apoptosis in HepG2 cells. In addition, TPN-Au(I)-MMTT and TPN-Au(I)-MMT also showed effective cytotoxicity against H1299 cells.
CONCLUSION: The present results showed that introduction of some five-membered heterocyclic compounds, especially MMT and MMTT, to TPN-Au(I) improved the cytotoxicity against solid cancer cells.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Current pharmaceutical design - 29(2023), 12 vom: 07., Seite 957-965 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sano, Naoyuki [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 29.05.2023 Date Revised 03.06.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1381612829666230407094658 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355371421 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM355371421 | ||
003 | DE-627 | ||
005 | 20231226064215.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1381612829666230407094658 |2 doi | |
028 | 5 | 2 | |a pubmed24n1184.xml |
035 | |a (DE-627)NLM355371421 | ||
035 | |a (NLM)37032505 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sano, Naoyuki |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cytotoxic Activity of Unique Synthesized Five-membered Heterocyclic Compounds Coordinated with Tiopronin Monovalent |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.05.2023 | ||
500 | |a Date Revised 03.06.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a BACKGROUND: We recently synthesized a compound in which 5-mercapto-1-methyltetrazole (MM4) was coordinated to tiopronin monovalent (TPN-Au(I)) and reported its cytotoxic activity against human leukemia cells in vitro</i> | ||
520 | |a OBJECTIVE: We further synthesized other heterocyclic compounds coordinated with TPN-Au(I) and assessed their cytotoxic activity against hepatocellular carcinoma HepG2 and lung cancer cell line H1299 in vitro</i> | ||
520 | |a METHODS: Seven kinds of compounds were synthesized by introducing a five-membered heterocyclic compound into TPN-Au(I). The number of viable cells was counted by a trypan blue dye exclusion assay. Fluorescence conjugated-Annexin V and propidium iodide were used for the apoptosis analysis | ||
520 | |a RESULTS: Seven compounds were successfully synthesized. Among these compounds, TPN-Au(I)-MTZ (3- mercapto-1,2,4-triazole), TPN-Au(I)-MMT (2-mercapto-5-methyl-1,3,4-thiadiazole), and TPN-Au(I)-MMTT (2-mercapto-5-methylthio-1,3,4-thiadiazole) effectively suppressed the proliferation and induced apoptosis in HepG2 cells. In addition, TPN-Au(I)-MMTT and TPN-Au(I)-MMT also showed effective cytotoxicity against H1299 cells | ||
520 | |a CONCLUSION: The present results showed that introduction of some five-membered heterocyclic compounds, especially MMT and MMTT, to TPN-Au(I) improved the cytotoxicity against solid cancer cells | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a 2 | |
650 | 4 | |a 2-mercapto-5- methyl-1 | |
650 | 4 | |a 2-mercapto-5-methylthio-1 | |
650 | 4 | |a 3 | |
650 | 4 | |a 3-mercapto-1 | |
650 | 4 | |a 4-thiadiazole (MMT) | |
650 | 4 | |a 4-thiadiazole (MMTT) | |
650 | 4 | |a 4-triazole (MTZ) | |
650 | 4 | |a 5-membered heterocyclic compound | |
650 | 4 | |a Tiopronin monovalent (TPN-Au(I)) | |
650 | 4 | |a cytotoxicity | |
650 | 7 | |a Tiopronin |2 NLM | |
650 | 7 | |a C5W04GO61S |2 NLM | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Heterocyclic Compounds |2 NLM | |
700 | 1 | |a Yoshino, Hironori |e verfasserin |4 aut | |
700 | 1 | |a Sato, Yoshiaki |e verfasserin |4 aut | |
700 | 1 | |a Honma, Hideo |e verfasserin |4 aut | |
700 | 1 | |a Cordonier, Christopher E J |e verfasserin |4 aut | |
700 | 1 | |a Kashiwakura, Ikuo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical design |d 1998 |g 29(2023), 12 vom: 07., Seite 957-965 |w (DE-627)NLM095430172 |x 1873-4286 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2023 |g number:12 |g day:07 |g pages:957-965 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1381612829666230407094658 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2023 |e 12 |b 07 |h 957-965 |